She has published over a dozen primary research articles on synovial sarcoma, including pioneering work on the role of p53 in this disease. Dr. Brodin has been an active collaborator in the sarcoma community worldwide, sharing cell lines and vector constructs with others on request. Recently, Dr. Brodin began an active collaboration with Dr. Nielsen’s laboratory, developing new technologies to interrogate the synovial sarcoma complex and identify how it can be disrupted by targeted drug treatments.